Literature DB >> 18771952

Effects of nitrogen dioxide on human health: systematic review of experimental and epidemiological studies conducted between 2002 and 2006.

Ute Latza1, Silke Gerdes, Xaver Baur.   

Abstract

In order to assess health effects in humans caused by environmental nitrogen dioxide (NO(2)) a systematic review of studies in humans was conducted. MEDLINE database was searched for epidemiological studies and experiments on adverse effects of NO(2) published between 2002 and 2006. The evidence with regard to NO(2) exposure limits was assessed using the Scottish Intercollegiate Guidelines Network (SIGN) grading system and the modified three star system. Of the 214 articles retrieved 112 fulfilled the inclusion criteria. There was limited evidence that short-term exposure to a 1-h mean value below 200 microg NO(2)/m(3) is associated with adverse health effects provided by only one study on mortality in patients with severe asthma (*2+). The effect remained after adjusting for other air pollutants. There was moderate evidence that short-term exposure below a 24-h mean value of 50 microg NO(2)/m(3) at monitor stations increases hospital admissions and mortality (**2+). Evidence was also moderate when the search was restricted to susceptible populations (children, adolescents, elderly, and asthmatics). There was moderate evidence that long-term exposure to an annual mean below 40 microg NO(2)/m(3) was associated with adverse health effects (respiratory symptoms/diseases, hospital admissions, mortality, and otitis media) provided by generally consistent findings in five well-conducted cohort and case-control studies with some shortcomings in the study quality (**2+). Evidence was also moderate when the search was restricted to studies in susceptible populations (children and adolescents) and for the combination with other air pollutants. The most frequent reasons for decreased study quality were potential misclassification of exposure and selection bias. None of the high-quality observational studies evaluated was informative for the key questions due to the choice of the dose parameter (e.g., 1-week mean) and exposure levels above the limit values. Inclusion of study designs unlisted in the SIGN grading system did not bring additional evidence regarding exposures below the current air quality limit values for NO(2). As several recent studies reported adverse health effects below the current exposure limits for NO(2) particularly among susceptible populations regarding long-term exposure further research is needed. Apart from high-quality epidemiological studies on causality and the interaction of NO(2) with other air pollutants there is a need for double-blinded randomized cross-over studies among susceptible populations for further evaluation of the short-term exposure limits.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771952     DOI: 10.1016/j.ijheh.2008.06.003

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  30 in total

1.  Development and Evaluation of the R-LINE Model Algorithms to Account for Chemical Transformation in the Near-road Environment.

Authors:  Alejandro Valencia; Akula Venkatram; David Heist; David Carruthers; Saravanan Arunachalam
Journal:  Transp Res D Transp Environ       Date:  2018       Impact factor: 5.495

2.  The statistical evaluation and comparison of ADMS-Urban model for the prediction of nitrogen dioxide with air quality monitoring network.

Authors:  Audrius Dėdelė; Auksė Miškinytė
Journal:  Environ Monit Assess       Date:  2015-08-21       Impact factor: 2.513

3.  Assessing NO2 Concentration and Model Uncertainty with High Spatiotemporal Resolution across the Contiguous United States Using Ensemble Model Averaging.

Authors:  Qian Di; Heresh Amini; Liuhua Shi; Itai Kloog; Rachel Silvern; James Kelly; M Benjamin Sabath; Christine Choirat; Petros Koutrakis; Alexei Lyapustin; Yujie Wang; Loretta J Mickley; Joel Schwartz
Journal:  Environ Sci Technol       Date:  2020-01-14       Impact factor: 9.028

4.  Desferrioxamine inhibits protein tyrosine nitration: mechanisms and implications.

Authors:  Margaret A Adgent; Giuseppe L Squadrito; Carol A Ballinger; David M Krzywanski; Jack R Lancaster; Edward M Postlethwait
Journal:  Free Radic Biol Med       Date:  2012-06-15       Impact factor: 7.376

5.  Biological effects of inhaled nitrogen dioxide in healthy human subjects.

Authors:  P Brand; J Bertram; A Chaker; R A Jörres; A Kronseder; T Kraus; M Gube
Journal:  Int Arch Occup Environ Health       Date:  2016-05-07       Impact factor: 3.015

6.  Assessing the accuracy of commercially available gas sensors for the measurement of ambient ozone and nitrogen dioxide.

Authors:  Kelechi Isiugo; Nicholas Newman; Roman Jandarov; Sergey A Grinshpun; Tiina Reponen
Journal:  J Occup Environ Hyg       Date:  2018-11       Impact factor: 2.155

7.  Effect of dust exposure and nitrogen oxides on lung function parameters of German coalminers: a longitudinal study applying GEE regression 1974-1998.

Authors:  P Morfeld; B Noll; S F Büchte; R Derwall; V Schenk; H J Bicker; H Lenaerts; N Schrader; D Dahmann
Journal:  Int Arch Occup Environ Health       Date:  2010-04       Impact factor: 3.015

8.  Seasonal variation of indoor and outdoor air quality of nitrogen dioxide in homes with gas and electric stoves.

Authors:  Audrius Dėdelė; Auksė Miškinytė
Journal:  Environ Sci Pollut Res Int       Date:  2016-06-01       Impact factor: 4.223

Review 9.  Exposure to air pollution and COVID-19 severity: A review of current insights, management, and challenges.

Authors:  Nurshad Ali; Khandaker A Fariha; Farjana Islam; Moshiul A Mishu; Nayan C Mohanto; Mohammad J Hosen; Khaled Hossain
Journal:  Integr Environ Assess Manag       Date:  2021-05-20       Impact factor: 3.084

10.  Source attribution of health benefits from air pollution abatement in Canada and the United States: an adjoint sensitivity analysis.

Authors:  Amanda Joy Pappin; Amir Hakami
Journal:  Environ Health Perspect       Date:  2013-02-22       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.